...
首页> 外文期刊>European review for medical and pharmacological sciences. >MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6
【24h】

MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6

机译:通过下调SOX6,MiR-1269a在非小细胞肺癌中充当癌基因miRNA

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Lung cancer, especially non-small cell lung cancer (NSCLC), remains one of the leading death-causing malignant tumors worldwide. MicroRNAs (miRNAs) have been identified to participate in the development and progression of NSCLC. However, the role of miR-1269a in NSCLC still needs to be elucidated. The objective of this study was to investigate the function of miR-1269a in NSCLC and its underlying mechanism. PATIENTS AND METHODS: Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was utilized to measure the expression level of miR-1269a in NSCLC tissues and cell lines. After transfection with miR-1269a mimics or inhibitors, the expression level of miR-1269a in NSCLC was up- or down-regulated. Cell Counting Kit-8 (CCK-8) assay and colony formation assay were used to measure cell proliferation ability. Flow cytometry assay was applied to verify the cell cycle distributions of established cell lines. The potential target of miR-1269a was determined by using dual-luciferase and Western blot assays. RESULTS: miR-1269a was significantly over-expressed in NSCLC tissues than that in adjacent normal tissues. The expression of miR-1269a was also up-regulated in NSCLC-derived cell lines. Up-regulation of miR-1269a improved the abilities of cell proliferation, colony formation, and induced cell cycle transition. Meanwhile, down-regulation of miR-1269a decreased the capacities of cell proliferation, colony formation, and arrested the cell cycle. It was further implicated that SOX6 was verified as a target of miR-1269a in NSCLC and over-expressed SOX6 could rescue the effect of miR-1269a up-regulation. CONCLUSIONS: Our study demonstrated that miR-1299a could function as an onco-miRNA in NSCLC and promote NSCLC growth via down-regulating the expression of SOX6.
机译:目的:肺癌,尤其是非小细胞肺癌(NSCLC),仍然是全球范围内导致死亡的主要恶性肿瘤之一。 MicroRNA(miRNA)已被确定参与NSCLC的发展和进程。然而,仍然需要阐明miR-1269a在NSCLC中的作用。这项研究的目的是研究miR-1269a在NSCLC中的功能及其潜在机制。病人和方法:实时定量聚合酶链反应(qRT-PCR)用于检测miR-1269a在NSCLC组织和细胞系中的表达水平。用miR-1269a模拟物或抑制剂转染后,NSCLC中miR-1269a的表达水平上调或下调。使用Cell Counting Kit-8(CCK-8)测定和集落形成测定来测量细胞增殖能力。应用流式细胞术来验证已建立细胞系的细胞周期分布。 miR-1269a的潜在靶标通过使用双重荧光素酶和Western印迹测定法确定。结果:NSCLC组织中miR-1269a的表达明显高于邻近的正常组织。在NSCLC衍生的细胞系中,miR-1269a的表达也被上调。 miR-1269a的上调改善了细胞增殖,集落形成和诱导的细胞周期转变的能力。同时,miR-1269a的下调降低了细胞增殖,集落形成的能力,并阻止了细胞周期。进一步暗示SOX6被证实是NSCLC中miR-1269a的靶标,并且过表达的SOX6可以挽救miR-1269a上调的作用。结论:我们的研究表明,miR-1299a可以作为NSCLC中的癌基因miRNA并通过下调SOX6的表达来促进NSCLC的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号